-
DSP Healthcare Fund Regular Growth
Equity healthcare
Overview ( as on 26/05/23 )
NAV
₹21.96
Last change
₹0.21 +0.01%
Fund Size (AUM)
1243.08 Cr
Performance
-
Fund Details
DSP Healthcare Fund Regular Growth
as of 26/05/23
AUM
1243.08 Cr
Expense Ratio
2.15 %
Benchmark
S&P BSE Healthcare TR INR
ISIN
INF740KA1LD8
Fund Manager
Vinit Sambre
Exit Load
1.0% if redeemed within 0-12 months
0% if redeemed after 12 months
| Fund Performance | 1Y | 3Y | 5Y |
|---|---|---|---|
| DSP Healthcare Fund Regular Growth | 9.82% | 19.39% | - |
| S&P BSE Healthcare TR INR | -5.37% | 14.53% | 10.23% |
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd |
16.19% |
Cipla Ltd Shs Dematerialised |
9.73% |
Apollo Hospitals Enterprise Ltd |
6.76% |
Procter & Gamble Health Ltd |
5.95% |
Lupin Ltd |
5.82% |
Alkem Laboratories Ltd |
5.02% |
Alembic Pharmaceuticals Ltd |
4.91% |
Ipca Laboratories Ltd |
4.51% |
Suven Pharmaceuticals Ltd |
3.72% |
Indoco Remedies Ltd |
3.29% |
Sector Allocation
Healthcare |
97.83% |
Financial |
2.17% |
Asset Allocation
-
100%
Equity
-
0%
Others
-
0%
Debt
Risk and Return Category
Risk v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Return v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Related Funds
-
Nippon India Pharma Fund Payout Inc Dist cum Cap Wdrl
Equity healthcare-
Returns
-
18.39% (5Y)
-
-
Nippon India Pharma Fund Reinvestment Inc Dist cum Cap Wdrl
Equity healthcare-
Returns
-
18.39% (5Y)
-
-
DSP Healthcare Fund Regular Growth
Equity healthcare-
Returns
-
NA
-
-
SBI Healthcare Opportunities Fund Regular Reinvestment Inc Dist cum Cap Wdrl
Equity healthcare-
Returns
-
15.75% (5Y)
-
-
SBI Healthcare Opportunities Fund Regular Growth
Equity healthcare-
Returns
-
15.74% (5Y)
-
-
DSP Healthcare Fund Regular Payout of Income Distribution cum capital withdrawal option
Equity healthcare-
Returns
-
NA
-
